Author(s):
Kisan R. Jadhav, Vilasrao.J. Kadam, Sambhaji S. Pisal
Email(s):
krj24@rediffmail.com.
DOI:
Not Available
Address:
Kisan R. Jadhav 1*, Vilasrao.J. Kadam 1and Sambhaji S. Pisal2,
1 Department of Pharmaceutics, Bharati Vidyapeeth’s College of Pharmacy, CBD Belapur, Sector-8,Navi- Mumbai – 400 614, India
2 Department of Pharmaceutics, Bharati Vidyapeeth University, Poona College of Pharmacy, Erandwane, Pune- 411 038, India.
*Corresponding Author
Published In:
Volume - 1,
Issue - 1,
Year - 2008
ABSTRACT:
The purpose of the present study was to develop and investigate the suitability of lecithin organogel formulations for topical delivery of erythromycin (EM) in order to improve its chemical stability and in vitro drug release. Organogels containing 3% wt/wt of EM were prepared using pharmaceutically acceptable surfactant (lecithin) and isopropyl myristate (IPM) and subjected to physical studies (appearance, pH, sprediability and viscosity). The In vitro skin permeation from lecithin organogel, hydrogel and marketed cream was investigated using Keshary-Chien diffusion cell. The safety of optimized organogel was determined using histopathological investigation. The in vitro skin permeation study data showed that organogel significantly increased EM release as compared to hydrogel and marketed cream (Okamycin, Cipla Ltd.). The drug release from these formulations were in the following order, (lecithin-IPM organogel > hydrogel> marketed cream). Incorporating the drug in to lecithin- IPM organogel resulted in enhanced chemical stability of EM. The stability of EM was in the order of organogel > hydrogel> marketed cream. The histopathological investigation using rat’s abdominal skin demonstrated that the formulation is safe for dermatological purpose. Thus the present lecithin based organogel appears beneficial for topical delivery of EM in terms of easy preparation, safety, stability and low cost.
Cite this article:
Kisan R. Jadhav, Vilasrao.J. Kadam, Sambhaji S. Pisal. Stability Enhancement and In-vitro Skin Permeation of Erythromycin from Lecithin - IPM Organogel. Research J. Pharm. and Tech. 1(1): Jan.-Mar. 2008; Page 33-39.
Cite(Electronic):
Kisan R. Jadhav, Vilasrao.J. Kadam, Sambhaji S. Pisal. Stability Enhancement and In-vitro Skin Permeation of Erythromycin from Lecithin - IPM Organogel. Research J. Pharm. and Tech. 1(1): Jan.-Mar. 2008; Page 33-39. Available on: https://rjptonline.org/AbstractView.aspx?PID=2008-1-1-21